Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets (Parenthetical)

v3.25.0.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Amortized cost of securities available for sale $ 1,004,563 $ 967,031
Loans receivable, allowance for credit losses 70,147 69,462
Face amount of subordinated debentures 136,800 136,800
Unamortized discount and debt issuance costs $ 6,162 $ 6,788
Preferred stock par value (in USD per share) $ 0.001 $ 0.001
Preferred stock authorized (shares) 10,000,000 10,000,000
Preferred stock issued (shares) 0 0
Common stock par value (in USD per share) $ 0.001 $ 0.001
Common stock authorized (shares) 62,500,000 62,500,000
Common stock issued (shares) 34,151,464 33,918,035
Common stock outstanding (shares) 30,195,999 30,368,655
Accumulated other comprehensive loss, tax benefit $ 28,576 $ 29,058
Treasury stock (shares) 3,955,465 3,549,380